The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMPACT of putative chemopreventative agents on prostate cancer diagnosis.
 
Hanan Goldberg
No Relationships to Disclose
 
Faizan Moshin
No Relationships to Disclose
 
Zachary William Abraham Klaassen
No Relationships to Disclose
 
Thenappan Chandrasekar
No Relationships to Disclose
 
Christopher J.D. Wallis
No Relationships to Disclose
 
Jaime Omar Herrera Cáceres
No Relationships to Disclose
 
Ardalan Ahmed
No Relationships to Disclose
 
Shabbir M.H. Alibhai
Honoraria - Astellas Scientific and Medical Affairs Inc
 
Alejandro Berlin
No Relationships to Disclose
 
Refik Saskin
No Relationships to Disclose
 
Robert James Hamilton
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
 
Neil Eric Fleshner
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen Oncology; Sanofi
Consulting or Advisory Role - Hybridyne Health
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Ferring (Inst); Janssen Oncology (Inst); Nucleix (Inst); Progenix (Inst); Spectracure (Inst)